NEUROENDOCRINE CANCER OF THE PROSTATE METASTATIC

NEUROENDOCRINE CANCER OF THE PROSTATE METASTATIC was reported 13 times

These drugs are most commonly taken by patients reporting NEUROENDOCRINE CANCER OF THE PROSTATE METASTATIC:

# Drug Count
0 ABIRATERONE 1
1 ABIRATERONE ACETATE 1
2 APALUTAMIDE 1
3 DAROLUTAMIDE 1
4 DOCETAXEL 1
5 DOCETAXEL ANHYDROUS 1
6 PREDNISONE 1